RxDoctor Payments Data

Matthew Deorio, MD

Foot and Ankle Surgery · Huntsville, ALNPI 1366422727

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $39,736 of the $48,776 with a category attached, or 81.5%. Exactech, Inc. accounts for 87.7% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $41,175, more than ten times the $1,902 reported in 2019.

$48,776in general payments, 2019–2025

Across 161 payments — averaging $302.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exactech, Inc.$43K
  • Stryker$2K
  • Paragon 28, Inc.$921
  • Smith+Nephew$452
  • Bioventus LLC$249
  • Prime Surgical, LLC$247
  • plus $2K from 26 others

What the payments were for

  • Royalty or licence$39,73681%
  • Travel & lodging$1,7474%
  • Food & beverage$7,29315%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,776 in reported general payments places this provider in the 85th percentile of 40 foot and ankle surgery providers in Alabama.

See all foot and ankle surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$231,026
Medicare patients
466
Services billed
2,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen185$1,473
Ondansetron Hcl168$712
Meloxicam69$378
Clindamycin Hcl21$301
Gabapentin46$298
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$152
Celecoxib11$108
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$97
Tramadol Hcl23$68

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →